The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2042253
Abstract: ABSTRACT Introduction To prevent damage from an immune response against autoantigens and toxins originating from the gut, the liver promotes an immune-tolerant milieu providing fertile ground for immune escape of cancer cells. Therefore, the use… read more here.
Keywords: blockade; dual icis; hepatocellular carcinoma; dual checkpoint ... See more keywords